3D printing technology could make heart surgery safer for children with congenital anomaly Three-dimensional printing technology could make medical procedures safer for children with congenital heart disease and decrease the duration along with the number of invasive procedures needed. Richard Kim, MD, a cardiac surgeon at Children's Hospital Los Angeles, recently used a 3D printed heart as a model to plan a life-saving procedure for his young individual, Esther Perez. The child was created with a rare, life-threatening cardiac defect viagrapourfemme.net/frigidit-la-froideur-sexuelle-de-la-femme.html . Esther acquired a ventricular septal defect, a common congenital anomaly fairly.
The brand new AMSBIO 3D Spheroid Proliferation/Viability Assay offers a useful device for modeling tumor response in vitro. The kit utilises a 3D Lifestyle Qualified 96 Well Spheroid Formation Plate alongside a specialised Spheroid Formation Extracellular Matrix to drive aggregation and/or spheroid formation of cells. Upon completion of spheroid formation, the spheroid may be treated with pharmacological agents to judge tumor viability after drug treatment. Tumor spheroid expansion is normally visualized microscopically and may be quantitated through picture analysis software for real-period and label free evaluation. Towards the end of the assay, cell viability may be assessed by fluorescence using Resazurin. The 3D Spheroid Fluorometric Proliferation/Viability Assay provides an in vitro, standardized, three-dimensional, high content material format for inducing multicellular tumor spheroid formation and quantitating cell viability within the spheroids in response to pharmacological treatment.